SEC Form 4 · accession 0001735276-18-000011
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Colleen F Reitan
Director
Period of report
Jun 1, 2018
Accepted (ET)
Jun 4, 2018 · 4:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $100.65 | Jun 1, 2018 | A | 18,000 | A | — | Jun 1, 2028 | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F1The stock option will vest as to one third of the shares on each of the first, second and third anniversaries of the date of grant.